Executive order is chance to expand kidney donation, JAMA article says

September 23, 2019

Members of the University Transplant Center, a clinical partnership of UT Health San Antonio and University Health System, authored a viewpoint piece published Sept. 20 in the Journal of the American Medical Association. In the article, Elizabeth Thomas, D.O., Jennifer Milton, RN, M.B.A., and Francisco G. Cigarroa, M.D., discussed the Advancing American Kidney Health Executive […]

Coveted NCI award comes to Sung, UT Health San Antonio

September 17, 2019

UT Health San Antonio biochemist Patrick Sung, D.Phil., one of the world’s leading experts on BRCA1 and BRCA2 cancer biology, has just received a highly competitive National Cancer Institute (NCI) Outstanding Investigator Award. Dr. Sung is the first faculty member in UT Health San Antonio history to capture this prestigious NCI award, which is bestowed […]

Rockwood honored as an AOA Pillar of the Orthopaedic Profession

September 13, 2019

Charles A. Rockwood, Jr., M.D., FAOA, of UT Health San Antonio has been honored by the American Orthopaedic Association as an AOA Pillar of the Orthopaedic Profession for his tremendous contributions to orthopaedic surgery. The effort to recognize Dr. Rockwood was led by Bernard F. Morrey, M.D., FAOA, with the generous support of many colleagues, […]

Noted heart failure expert to join UT Health San Antonio

September 10, 2019

UT Health San Antonio has recruited Allen S. Anderson, M.D., FACC, FAHA, to direct and expand the university’s many initiatives in cardiology and cardiovascular disease education and research. Dr. Anderson is a nationally recognized leader in heart failure and cardiac transplantation at the Northwestern University Feinberg School of Medicine in Chicago. On Nov. 1, he […]

Study identifies easier way to assess what stroke does to the brain

September 9, 2019

Highlights: A small genetic “fingerprint,” known as a microRNA, was linked with stroke and the long- term effects of stroke on your body. MicroRNA levels can be measured from a simple blood test, creating the opportunity for a more affordable and more practical option than examining actual brain tissue or using other conventional tests. MicroRNAs […]

FDA approves new MPN drug that Mays Cancer Center director helped develop

September 9, 2019

SAN ANTONIO (Sept. 9, 2019)  ̶  September is Blood Cancer Awareness Month, and this year patients with myelofibrosis, a rare blood cancer, have reason to celebrate. In mid-August, the U.S. Food and Drug Administration approved the first new medication in nearly a decade for patients with myelofibrosis. Ruben Mesa, M.D., FACP, was part of the […]